Effects of Intravenous Dobutamine on Coronary Vasomotion in Humans

Journal of the American College of Cardiology

Volumn 42, Issue 9, 2003, Pages 1596-1601

  Barbato, Emanuele ^a   Bartunek, Jozef ^a   Wyffels, Eric ^a   Wijns, William ^a   Heyndrickx, Guy R ^a   De Bruyne, Bernard ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ARGININE; DOBUTAMINE; ISOSORBIDE DINITRATE; PHENTOLAMINE; SODIUM CHLORIDE;

ALPHA ADRENERGIC STIMULATION; ANGIOCARDIOGRAPHY; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIUM LESION; EPICARDIUM; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTRACORONARY INFUSION; MALE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY;

EID: 0242543982     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.03.001     Document Type: Article

References (33)

1. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991;83:1605-14.
2. Mazeika PK, Nadazdin A, Oakley CM, et al. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992;19:1203-11.
3. Bartunek J, Wijns W, Heyndrickx GR, et al. Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine. Circulation 1999;100:243-9.
4. Petropoulakis PN, Pavlides GS, Manginas AN, et al. Intracoronary flow velocity measurements in adjacent stenotic and normal coronary arteries during incremental intravenous dobutamine stress and intracoronary adenosine injection. Cathet Cardiovasc Interv 1999;48:1-9.
5. Bartunek J, Marwick TH, Rodrigues ACT, et al. Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol 1996;27:1429-36.
6. Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 1990;81:850-9.
7. Nabel EG, Ganz P, Gordon JB, et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressure test. Circulation 1988;77:43-52.
8. Gage JE, Hess OM, Murakami T, et al. Vasoconstriction of stenotic coronaries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986;73:865-76.
9. Gregorini L, Marco J, Kozàkovà M, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999;99:482-90.
10. Drexler H, Zeiher AM, Meinzer K, et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546-50.
11. Tousoulis D, Davies G, Tentolouris C, et al. Coronary stenosis dilatation induced by L-arginine. Lancet 1997;349:1812-3.
12. Vatner SF, Hintze TH, Macho P. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog. Circ Res 1982;51:56-66.
13. Hodgson JMB, Cohen MD, Szentpetery S, et al. Effects of regional alpha-and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstresses humans. Circulation 1989;79:797-809.
14. 1-adrenergic stimulation in vitro. J Cardiovasc Pharmacol 1995;25:134-41.
15. Palmer RMJ, Ferrige AG, Moncada S, et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
16. Parent R, Al-Obaidi M, Lavallée M. Nitric oxide formation contributes to beta-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 1993;73:241-51.
17. Ghaleh B, Béa ML, Dubois-Randé JL, et al. Endothelial modulation of beta-adrenergic dilation of large coronary arteries in conscious dogs. Circulation 1995;92:2627-35.
18. Vatner SF, McRitchie RJ, Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics and distribution of cardiac output in conscious dogs. J Clin Invest 1974;53:1265-73.
19. Pierard LA, Berthe C, Albert A, et al. Hemodynamic alterations during ischemia induced by dobutamine stress testing. Eur Heart J 1989;10:783-90.
20. 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 1993;87:1264-74.
21. Tesfamariam B, Cohen RA. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ Res 1988;63:720-5.
22. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986;73:662-7.
23. Vita JA, Treasure CB, Yeung AC, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992;85:1390-7.
24. Seiler C, Hess OM, Buechi M, et al. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993;88:2139-48.
25. Frielingsdorf J, Seiler C, Kaufmann P, et al. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation 1996;93:1380-7.
26. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-100.
27. Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551-6.
28. 1-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol 1985;5:840-6.
29. Julius BK, Vassalli G, Mandinov L, et al. Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries. J Am Coll Cardiol 1999;33:1499-505.
30. Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia: head to head comparison of exercise, dobutamine and dipyridamole tests. Circulation 1994;90:1168-76.
31. Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995;26:18-25.
32. El-Tamimi H, Mansour M, Pepine CJ, et al. Circadian variation in coronary tone in patients with stable angina: protective role of endothelium. Circulation 1995;92:3201-5.
33. Shaw JA, Chin-Dusting JPF, Kingwell BA, et al. Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 2001;103:806-12.